Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study
- PMID: 27515592
- PMCID: PMC5053788
- DOI: 10.2215/CJN.02170216
Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study
Abstract
Background and objectives: Patients on dialysis are known to have higher risk for gastrointestinal (GI) bleeding. However, data on mild to moderate CKD, particularly elevated albuminuria, are limited.
Design, setting, participants, & measurements: Among 11,088 participants in the Atherosclerosis Risk in Communities (ARIC) Study, we investigated the association of eGFR and urinary albumin-to-creatinine ratio (ACR) with risk for hospitalization with GI bleeding. Kidney measures were assessed at visit four (1996-1998), and follow-up was continued through 2011.
Results: During a median follow-up of 13.9 years, 686 first incident hospitalizations with GI bleeding were observed (incidence rate, 4.9 per 1000 person-years [95% confidence interval (95% CI), 4.5 to 5.3]). Multivariable Cox proportional hazards models revealed that both lower eGFR and higher ACR were associated with higher risk for GI bleeding. With eGFR≥90 ml/min per 1.73 m2 as a reference, risk for GI bleeding was significant in moderately decreased eGFR of 30-59 ml/min per 1.73 m2 (hazard ratio [HR], 1.51; 95% CI, 1.13 to 2.02), and was highest in severely decreased eGFR<30 ml/min per 1.73 m2 (HR, 7.06; 95% CI, 3.91 to 12.76). Compared with ACR<10 mg/g, risk for GI bleeding became significantly higher in mild albuminuria with ACR 10-29 mg/g (HR, 1.36; 95% CI, 1.08 to 1.69), and was nearly double in moderate and severe albuminuria (HR, 2.13; 95% CI, 1.66 to 2.71 for ACR 30-299 mg/g, and HR, 2.07; 95% CI, 1.33 to 3.22 for ACR≥300 mg/g). These results were largely consistent in demographic and clinical subgroups and independent of incident cardiovascular events or dialysis during follow-up.
Conclusions: Individuals with even mild to moderate CKD warrant clinical attention regarding the risk of hospitalization with GI bleeding.
Keywords: Albumins; Atherosclerosis; Attention; Follow-Up Studies; Humans; Incidence; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk; albuminuria; chronic kidney disease; chronic kidney failure; chronic renal failure; creatinine; gastrointestinal complications; glomerular filtration rate; hospitalization; kidney; proteinuria; renal dialysis.
Copyright © 2016 by the American Society of Nephrology.
Figures


References
-
- Milenkovic M, Russo CA, Elixhauser A: Hospital Stays for Gastrointestinal Diseases, 2004., HCUP Statistical Brief #12. September 2006. Agency for Healthcare Research and Quality, R, Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb12.pdf - PubMed
-
- Lanas A, García-Rodríguez LA, Polo-Tomás M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, Perez-Gisbert J, Bujanda L, Castro M, Muñoz M, Rodrigo L, Calvet X, Del-Pino D, Garcia S: Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 104: 1633–1641, 2009 - PubMed
-
- Rincon F, Mayer SA: The epidemiology of intracerebral hemorrhage in the United States from 1979 to 2008. Neurocrit Care 19: 95–102, 2013 - PubMed
-
- Vanassche T, Hirsh J, Eikelboom JW, Ginsberg JS: Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials. Thromb Haemost 112: 918–923, 2014 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- K08 HL125100/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- T32 HL007024/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources